Bristol-Myers Squibb Company (LON:0R1F)

London flag London · Delayed Price · Currency is GBP · Price in USD
47.34
+0.92 (1.98%)
At close: Aug 13, 2025
1.29%
Market Cap 71.77B
Revenue (ttm) 34.82B
Net Income (ttm) 3.69B
Shares Out n/a
EPS (ttm) 1.81
PE Ratio 19.48
Forward PE 7.45
Dividend 1.89 (4.13%)
Ex-Dividend Date Jul 3, 2025
Volume 9,942
Average Volume 107,128
Open 46.58
Previous Close 46.42
Day's Range 46.50 - 47.65
52-Week Range 41.99 - 63.17
Beta 0.37
RSI 54.73
Earnings Date Jul 31, 2025

About LON:0R1F

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Sector Healthcare
Founded 1887
Employees 34,100
Stock Exchange London Stock Exchange
Ticker Symbol 0R1F
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.